Guadecitabine Extension Study

NCT03603964 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

INDUSTRY

Sponsor class

Stopped Early termination not due to patient safety

Conditions

Acute Myeloid Leukemia
Myeloid Dysplastic Syndrome

Interventions

DRUG: Guadecitabine

Sponsor

Astex Pharmaceuticals, Inc.